About Q100 Life Sciences Private Limited
Data last updated:
Q100 Life Sciences Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 05 December 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24110TG2020PTC146589. Its GSTIN is 36AAACQ7094H1Z5 (Telangana).
The company has an authorised share capital of ₹60 Lakh and a paid-up capital of ₹51 Lakh. It is led by directors including Dharma Tej Reddy and Janardhan.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.188 Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.
As per the financials filed for FY 2024, the company reported a revenue of ₹11.48 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹14.19 Lakh (net margin 1.2%) and EBITDA of ₹20.6 Lakh (EBITDA margin 1.8%). Revenue has grown at a compounded annual rate (CAGR) of 144% over three years.
Court records list 3 cases involving the company, including 3 filed against it; 3 cases are pending.
For more details, the company can be reached via its website q100lifesciences.com.
Company details
Contact details
Q100 Life Sciences Private Limited's registered office is in Hyderabad, Telangana. Its website is q100lifesciences.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressPlot No.188 Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072
- IndustryPharma, API Manufacturers
To see the full contact details of Q100 Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Q100 Life Sciences is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Q100 Life Sciences Private Limited, buy the company report.
Financials of Q100 Life Sciences Private Limited
FY 2025 filings availableQ100 Life Sciences Private Limited reported revenue of ₹11.48 Cr (up 475% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 144% over three years, including 475% growth in the latest year. EBITDA rose 268% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹20.6 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹14.19 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.8% | |||
| Net Profit Margin | 1.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Q100 Life Sciences Private Limited, buy the company report.
Board of directors of Q100 Life Sciences Private Limited
Q100 Life Sciences has 5 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Janardhan Also directs: Nikash Infra Projects LLP, SJK Properties Private Limited | Additional Director | 24 Nov 2021 | 4 Years 10 Months | Current |
| Raghunathareddy Pulim | Additional Director | 24 Nov 2021 | 4 Years 10 Months | Current |
| Dharma Tej Reddy Also directs: Unykloud Technologies Private Limited | Director | 05 Dec 2020 | 5 Years 10 Months | Current |
| Rakesh Kolli | Additional Director | 18 Jan 2024 | 2 Years 9 Months | Current |
| Bonthu Kumari Aruna Also directs: Sai Bhargavi Foods Private Limited | Additional Director | 28 Apr 2025 | 1 Years 5 Months | Current |
Peer comparison
Q100 Life Sciences Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Srajan Automotors Private Limited | ₹11.49 Cr (FY 2024) | 50.0% | Udaipur, Rajasthan, India | |||
| Perfect Office Systems P Ltd | ₹11.49 Cr (FY 2025) | 45.0% | Mumbai, Maharashtra, India | |||
| Josh Commercial Private Limited | ₹11.49 Cr (FY 2024) | -36.0% | Kolkata, West Bengal, India | |||
| Opg Buildwell Private Limited | ₹11.49 Cr (FY 2025) | 78.0% | Delhi, India | |||
| Om Bhakti Samagri Kreations Private Limited | ₹11.48 Cr (FY 2025) | 35.0% | Bangalore, Karnataka, India | |||
| Q100 Life Sciences Private Limitedthis company | ₹11.48 Cr (FY 2024) | ₹14.19 Lakh | 1.2% | 475.0% | Hyderabad, Telangana, India | |
| Pinnaclesafe Technologies Private Limited | ₹11.48 Cr (FY 2025) | -36.0% | Thane, Maharashtra, India | |||
| Attb Trading Company Private Limited | ₹11.48 Cr (FY 2016) | 18.0% | Bally, West Bengal, India | |||
| Mailbox Fashions Private Limited | ₹11.48 Cr (FY 2025) | -12.0% | Ludhiana, Punjab, India | |||
| Jap Agencies Private Limited | ₹11.48 Cr (FY 2025) | 9.0% | Margao, Goa, India | |||
| Abs Instruments Private Limited | ₹11.48 Cr (FY 2025) | 21.0% | Guindy, Chennai, Tamil Nadu, India |
To see the full peer comparison of Q100 Life Sciences Private Limited, buy the company report.
Auditor
Q100 Life Sciences Private Limited is audited by AMARESHWARGUDA for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| AMARESHWARGUDA | FY 2023 | 221066 |
Shareholding
The shareholding of Q100 Life Sciences Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Q100 Life Sciences Private Limited, buy the company report.
Legal cases
Q100 Life Sciences Private Limited has 3 court cases on record: 3 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Hyderabad Central, Telangana | Cheque dishonour complaint | Filed against the company by M/S. Deccan Remedies Limited Rep. by Its Chief Financial Officer Akkali Santosh Kumar | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summary Case) | Filed against the company by Khushbu Chemicals | Pending |
To see the full case history of Q100 Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Q100 Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Q100 Life Sciences Private Limited has 1 active EPFO establishment as of Mar 23, 2024.
GST
Q100 Life Sciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACQ7094H1Z5 | Telangana | Active | 15 Dec 2020 |
To see the full GST registrations and return filing status of Q100 Life Sciences Private Limited, buy the company report.
Recent activity
Q100 Life Sciences Private Limited has 9 board changes on record since 2020: 5 appointments and 4 cessations. The latest: Bonthu Kumari Aruna was appointed as Additional Director on 28 Apr 2025.
Frequently asked questions
Q100 Life Sciences is an active private limited company based in Hyderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 05 December 2020 (6+ years old) and is registered under CIN U24110TG2020PTC146589.
Q100 Life Sciences has 5 current directors:
- Janardhan - Additional Director
- Raghunathareddy Pulim - Additional Director
- Dharma Tej Reddy - Director
- Rakesh Kolli - Additional Director
- Bonthu Kumari Aruna - Additional Director
The latest financial statements of Q100 Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Q100 Life Sciences is 36AAACQ7094H1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Q100 Life Sciences is U24110TG2020PTC146589. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Q100 Life Sciences has 3 court cases on record: 3 filed against it. 3 are pending.
Q100 Life Sciences was incorporated on 05 December 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Q100 Life Sciences by revenue are Srajan Automotors Private Limited, Perfect Office Systems P Ltd, Josh Commercial Private Limited, Opg Buildwell Private Limited, Om Bhakti Samagri Kreations Private Limited and 5 more, all in the same principal business activity (retail trading).
Bonthu Kumari Aruna was appointed as Additional Director on 28 Apr 2025. Rakesh Kolli was appointed as Additional Director on 18 Jan 2024. Vemula Nageswara Rao ceased to be Director on 18 Jan 2024. Q100 Life Sciences has 9 board changes on record in total.
Q100 Life Sciences can be reached through the website q100lifesciences.com. Its registered office is in Hyderabad, Telangana, India.
The registered office of Q100 Life Sciences is at Plot No.188 Vivekananda Nagar Colony Kukatpally, Hyderabad, Telangana, India – 500072.